← Open Payments lookup

KRISTINE KUCERA: Open Payments

NPI 1699970368 · MELISSA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$184,465 in 438 payments from 20 companies in 2025. Trend: 2023 $221,341 · 2024 $167,102 · 2025 $184,465

Speaker / faculty: $127,618Consulting: $22,071Travel & lodging: $18,512Food & beverage: $8,768Speaker / faculty: $7,398Education: $99
CompanyPaymentsAmount
UCB, Inc.86$41,389
Janssen Biotech, Inc.61$37,702
ABBVIE INC.69$36,913
Galderma Laboratories, L.P.44$16,174
Novartis Pharmaceuticals Corporation22$12,407
SUN PHARMACEUTICAL INDUSTRIES INC.25$9,028
Amgen Inc.22$8,579
E.R. Squibb & Sons, L.L.C.14$7,283
PFIZER INC.14$5,550
Takeda Pharmaceuticals U.S.A., Inc.6$3,827

Products named: Bimzelx, TREMFYA, RINVOQ, NEMLUVIO, ILUMYA, COSENTYX, Sotyktu, CIBINQO.

Industry payments across TX — which companies pay providers there.